Orgenesis
MD - GermantownBiotechnology
Focus: Orgenesis is a newly founded (2024) biotechnology company specializing in autologous cellular conversion for metabolic diseases, headquartered in Germantown, Maryland. The company is at a very early stage with minimal disclosed operational scale.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Open Jobs
25+32 this month
Hot — 42 jobs added in 30d
Net +32 (42 new, 10 removed). Aggressive expansion phase.
Should You Work at Orgenesis?
AI assessmentOrgenesis represents a high-risk, high-potential-upside bet suitable only for founders-mentality scientists willing to endure operational uncertainty in exchange for early equity exposure and scientific autonomy.
Why Work Here
- Ground-floor opportunity at a newly founded company (2024) with potential to shape early-stage culture and scientific direction in an emerging modality (autologous cellular conversion)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Liver biopsy collection
Type 1 DiabetesClinical Trials (1)
NCT04038931Collection of Human Liver Biopsy and Whole Blood Samples From T1DM, TP or PP Patients for Potential Use for Insulin Producing Cells in Future Clinical Studies
N/AHelp build intelligence for Orgenesis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.